MEK Inhibitor News and Research

RSS
Array BioPharma signs agreement with Novartis for worldwide development of ARRY-162

Array BioPharma signs agreement with Novartis for worldwide development of ARRY-162

Ardea Biosciences' revenues total $8.3M for three months ended December 31, 2009

Ardea Biosciences' revenues total $8.3M for three months ended December 31, 2009

StemCells receives U.S. patent for propagation and/or derivation of embryonic stem cells

StemCells receives U.S. patent for propagation and/or derivation of embryonic stem cells

New approach for understanding how drug resistance occurs in leukemia

New approach for understanding how drug resistance occurs in leukemia

Results of Phase 2 rheumatoid arthritis clinical trial announced

Results of Phase 2 rheumatoid arthritis clinical trial announced

Array Biopharma reports Q4 and full year 2009 financials

Array Biopharma reports Q4 and full year 2009 financials

Advance in K-Ras-mutated cancer research

Advance in K-Ras-mutated cancer research

Gene study sheds new light on lung cancer

Gene study sheds new light on lung cancer

Newly discovered ERK pathway proteins related to CagA induced disease

Newly discovered ERK pathway proteins related to CagA induced disease

Combination targets offer new hope in fight against cancer

Combination targets offer new hope in fight against cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.